Sides Bicker Over Bifurcation In Mirapex Case
Pfizer and the other defendants in the Mirapex case are pushing for the litigation to be broken up so that the jury is not swayed by financial considerations when determining liability...To view the full article, register now.
Already a subscriber? Click here to view full article